The IPS values (ips_ctla4_neg_pd1_pos, ips_ctla4_pos_pd1_neg, ips_ctla4_pos_pd1_neg, and ips_ctla4_pos_pd1_pos) have been validated in predicting cancer patients’ responses to anti-CTLA-4 treatment. Here, CTLA4 is linked to cancer.